Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Key targets and relevant inhibitors for the drug discovery of tuberculosis.

Xiong X, Xu Z, Yang Z, Liu Y, Wang D, Dong M, Parker EJ, Zhu W.

Curr Drug Targets. 2013 Jun 1;14(6):676-99. Review.

PMID:
23547780
2.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
3.

[Recent progress in mycobacteriology].

Okada M, Kobayashi K.

Kekkaku. 2007 Oct;82(10):783-99. Japanese.

PMID:
18018602
4.

[Frontier of mycobacterium research--host vs. mycobacterium].

Okada M, Shirakawa T.

Kekkaku. 2005 Sep;80(9):613-29. Japanese.

PMID:
16245793
5.

[Prospects for development of new antituberculous drugs].

Tomioka H.

Kekkaku. 2002 Aug;77(8):573-84. Japanese.

PMID:
12235850
6.

Identification and validation of novel drug targets in tuberculosis.

Duncan K.

Curr Pharm Des. 2004;10(26):3185-94. Review.

PMID:
15544508
7.

Novel targets in M. tuberculosis: search for new drugs.

Lamichhane G.

Trends Mol Med. 2011 Jan;17(1):25-33. doi: 10.1016/j.molmed.2010.10.004. Epub 2010 Nov 9. Review.

PMID:
21071272
8.

Host-pathogen interactions in latent Mycobacterium tuberculosis infection: identification of new targets for tuberculosis intervention.

Lin MY, Ottenhoff TH.

Endocr Metab Immune Disord Drug Targets. 2008 Mar;8(1):15-29. Review.

PMID:
18393920
9.

The challenge of new drug discovery for tuberculosis.

Koul A, Arnoult E, Lounis N, Guillemont J, Andries K.

Nature. 2011 Jan 27;469(7331):483-90. doi: 10.1038/nature09657. Review.

PMID:
21270886
10.

Targeting tuberculosis: a glimpse of promising drug targets.

Arora N, Banerjee AK.

Mini Rev Med Chem. 2012 Mar;12(3):187-201. Review.

PMID:
22356190
11.

Tuberculosis drug targets.

Zhang Y, Amzel LM.

Curr Drug Targets. 2002 Apr;3(2):131-54. Review.

PMID:
11958297
12.

Advances in the development of new tuberculosis drugs and treatment regimens.

Zumla A, Nahid P, Cole ST.

Nat Rev Drug Discov. 2013 May;12(5):388-404. doi: 10.1038/nrd4001. Review.

PMID:
23629506
13.

In silico analyses for the discovery of tuberculosis drug targets.

Chung BK, Dick T, Lee DY.

J Antimicrob Chemother. 2013 Dec;68(12):2701-9. doi: 10.1093/jac/dkt273. Epub 2013 Jul 9. Review.

14.

Computational biology in anti-tuberculosis drug discovery.

Murphy DJ, Brown JR.

Infect Disord Drug Targets. 2009 Jun;9(3):319-26. Review.

PMID:
19519485
15.

Development of new anti-tuberculosis drug candidates.

Shi R, Sugawara I.

Tohoku J Exp Med. 2010 Jun;221(2):97-106. Review.

16.
17.

Current strategies for identifying and validating targets for new treatment-shortening drugs for TB.

Williams KJ, Duncan K.

Curr Mol Med. 2007 May;7(3):297-307. Review.

PMID:
17504114
18.

New frontiers in the therapy of tuberculosis: fighting with the global menace.

Chhabria M, Jani M, Patel S.

Mini Rev Med Chem. 2009 Apr;9(4):401-30. Review.

PMID:
19356120
19.

Tuberculosis: current treatment, diagnostics, and newer antitubercular agents in clinical trials.

Ahsan MJ, Ansari MY, Yasmin S, Jadav SS, Kumar P, Garg SK, Aseri A, Khalilullah H.

Infect Disord Drug Targets. 2015;15(1):32-41. Review.

PMID:
25246035
20.

The resumption of consumption -- a review on tuberculosis.

Ducati RG, Ruffino-Netto A, Basso LA, Santos DS.

Mem Inst Oswaldo Cruz. 2006 Nov;101(7):697-714. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk